Department of Coronary Artery Disease, Jagiellonian University Medical College, 80 Pradnicka Street, 31-202, Krakow, Poland.
Gdansk University of Technology, 11/12 Narutowicza Street, 80-233, Gdansk, Poland.
Clin Res Cardiol. 2019 Aug;108(8):950-962. doi: 10.1007/s00392-019-01425-x. Epub 2019 Feb 1.
The tightly packed arrays of polyhedral erythrocytes, polyhedrocytes, formed during thrombus contraction, have been detected in some intracoronary thrombi (ICT) obtained from patients with ST-segment elevation myocardial infarction (STEMI). We sought to investigate determinants of polyhedrocyte content in ICT and its association with reperfusion in STEMI.
We assessed the composition of ICT obtained during thrombectomy within 12 h since the symptom onset in 110 STEMI patients, following 300 mg of aspirin (n = 110) and 600 mg of clopidogrel (n = 75). The predominance of fibrin, erythrocytes, polyhedrocytes or platelets was evaluated using scanning electron microscopy.
Polyhedrocytes were found in 34 (30.9%) ICT, in which they covered 20-50% (median 38.8%) fields of view. Patients with polyhedrocytes in ICT had lower median minimal reference infarct-related artery (IRA) diameter by 20% (p < 0.0001) and area by 31% (p < 0.0001) versus those without polyhedrocytes. Time of ischemia showed association with the polyhedrocyte content (r = 0.26, p = 0.007). By multivariate analysis, minimal IRA diameter (β = - 0.50, p < 0.0001) and ischemia time (β = 0.20, p = 0.035) independently affected polyhedrocyte content in ICT (R = 0.45, p < 0.0001). Patients with ischemia time of > 3 h and polyhedrocytes present in ICT had more frequently TIMI-2/3 flow after thrombus aspiration (96% vs. 67%, p = 0.02) and final TIMI-2/3 myocardial perfusion grade (92% vs. 57%, p = 0.044) versus those without polyhedrocytes.
Our findings indicate that the presence of polyhedrocytes in ICT, observed in one-third of STEMI patients, is associated with smaller minimal IRA diameter, prolonged ischemia and their formation in late presenters is associated with more effective thrombus aspiration and better myocardial reperfusion.
在一些 ST 段抬高型心肌梗死(STEMI)患者的冠状动脉内血栓(ICT)中,已经检测到血栓收缩时形成的多面红细胞聚集体,即多面体红细胞。我们试图研究 ICT 中多面体红细胞含量的决定因素及其与 STEMI 再灌注的关系。
我们评估了 110 例 STEMI 患者在症状发作后 12 小时内行血栓切除术时 ICT 的组成,这些患者分别给予 300mg 阿司匹林(n=110)和 600mg 氯吡格雷(n=75)。使用扫描电子显微镜评估纤维蛋白、红细胞、多面体红细胞或血小板的优势。
34 例(30.9%)ICT 中发现有多面体红细胞,其中 20-50%(中位数 38.8%)视野被覆盖。与无多面体红细胞的 ICT 患者相比,多面体红细胞 ICT 患者的最小参考梗死相关动脉(IRA)直径中位数低 20%(p<0.0001),面积低 31%(p<0.0001)。缺血时间与多面体红细胞含量呈正相关(r=0.26,p=0.007)。多元分析显示,最小 IRA 直径(β=-0.50,p<0.0001)和缺血时间(β=0.20,p=0.035)独立影响 ICT 中的多面体红细胞含量(R=0.45,p<0.0001)。缺血时间>3 小时且 ICT 中存在多面体红细胞的患者经血栓抽吸后 TIMI-2/3 血流更频繁(96% vs. 67%,p=0.02),最终 TIMI-2/3 心肌灌注分级也更高(92% vs. 57%,p=0.044)。
我们的发现表明,三分之一 STEMI 患者的 ICT 中存在多面体红细胞,与最小 IRA 直径较小、缺血时间延长有关,且晚期出现的多面体红细胞与更有效的血栓抽吸和更好的心肌再灌注有关。